MIP
Life Sciences
International manufacturer of generic and specialized pharmaceuticals with a focus on anti-infectives
Überblick
MIP Pharma is an international manufacturer and distributor of generic and specialized pharmaceuticals, specializing in anti-infectives. Most of its products are manufactured in its own production facilities located in the Saarland region of Germany. With approximately 400 pharmaceutical approvals MIP generates revenues across 19 countries. The company plays a vital role in ensuring the strategic and independent supply of essential medicines, particularly within Germany.
Sector
Life Sciences
Investment
2020
Location
Blieskastel (DE)
Status
Active
MIP Pharma was acquired as part of a management buy-out to secure the succession of this second-generation family business and unlock its operational potential.
Investment Thesis
- Local producer and supplier of essential medicines, contributing to Germany’s strategic independence by reducing reliance on imports from China.
- A family business in its second generation with significant opportunities for operational optimization.
- Expansion of its leading position in targeted niche markets.
Value Creation
- Organic revenue growth through market expansion, strengthening of sales forces in key regions, and a strategic focus on high-potential products.
- Consolidation and modernization of existing production facilities to leverage cost synergies and implement state-of-the-art technologies for process optimization.
Sie haben Fragen?
Ihre Ansprechpartner zum Thema
Marvin Breuer
Associate